Tibet AIM Pharm. Inc. (002826.SZ) SHZ

18.38

-0.32(-1.71%)

Updated at October 17 03:04PM

Currency In CNY

Valuation

Market Cap1.9B
Enterprise Value1.5B
P/E Ratio78.79
PEG Ratio5.25
Price/Sales Ratio5.51
Price/Book Ratio4.52
Enterprise/Revenue5.15
Enterprise/EBITDA49.08

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.11

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue651.88M
Revenue/Share3.25
Gross Profit446.63M
EBITDA82.51M
Net Income45.93M
Diluted EPS0.25

Balance Sheet

Total Cash515.95M
Total Cash/Share2.75
Total Debt44.91M
Total Debt/Equity0.06
Current Ratio2.69
Book Value Per Share4.1

Price History

52-Week Change101.76
52-Week High26.83
52-Week Low8.18
Moving Average 50 Days20.38
Moving Average 200 Days15.53

Statistics

Average Volume14.35M
Shares Outstanding183.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.54
Payout Ratio0.45
Last Split FactorN/A
Last Split DateN/A